Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | PIM1 | P11309 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.43 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.43 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1925913 | 1.00 | CA12 (0.46) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL25474080 | 0.94 | HDAC8 (0.44) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL32106752 | 0.91 | PIM1 (0.45) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL1155344 | 0.91 | HDAC8 (0.47) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL30100127 | 0.91 | HDAC8 (0.47) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL2954967 | 0.91 | PIM1 (0.45) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL28056318 | 0.91 | MCL1 (0.49) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL18880008 | 0.91 | ALDH1A1 (0.45) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL29350427 | 0.91 | PIM1 (0.47) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL536536 | 0.91 | PIM1 (0.47) | CA12CA1CA2CA9PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118251034-A | Organic light emitting diode and organic light emitting device | 乐金显示有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118251039-A | Organic light emitting diode and organic light emitting device | 乐金显示有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-20260150576-A1 | HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2026-05-28 | — | — | US | disclosed |
| EP-4263544-B1 | INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE EMITTERS IN OLEDS | UDC IRELAND LTD (IE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4719022-A2 | NITROGEN-CONTAINING HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC Ireland Limited (IE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4519383-B1 | CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4676208-A2 | NITROGEN-CONTAINING HETERO-AROMATICS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4482913-B1 | NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-12-24 | — | — | EP | disclosed |
| EP-4263746-B1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-10-01 | — | — | EP | disclosed |
| US-20250295028-A1 | CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-09-18 | — | — | US | disclosed |
| EP-4172164-B1 | HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-08-27 | — | — | EP | disclosed |
| CN-111316461-B | Organic light emitting element | 东丽先端材料研究开发（中国）有限公司 | 2023-01-20 | — | — | CN | disclosed |
| CN-108123051-B | Light-emitting element, light-emitting device, electronic apparatus, display device, and lighting device | 株式会社半导体能源研究所 | 2022-12-09 | — | — | CN | disclosed |
| WO-2022253759-A1 | AN ORGANIC ELECTROLUMINESCENT DEVICE AND A COMPOUND FOR USE THEREIN | NOVALED GMBH (DE) | 2022-12-08 | — | — | WO | disclosed |
| EP-4099412-A1 | AN ORGANIC ELECTROLUMINESCENT DEVICE AND A COMPOUND FOR USE THEREIN | Novaled GmbH (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-115246813-A | High refractive index organic compound, cover layer material and light emitting element | 东丽先端材料研究开发（中国）有限公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-115000314-A | Light-emitting element, light-emitting device, electronic device, and lighting device | 株式会社半导体能源研究所 | 2022-09-02 | — | — | CN | disclosed |
| CN-107698531-B | Compound and organic electronic device thereof | 上海嵘彩光电材料有限公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-107665955-B | Light-emitting element, light-emitting device, electronic device, and lighting device | 株式会社半导体能源研究所 | 2022-05-13 | — | — | CN | disclosed |
| CN-108623546-B | Compound and organic electronic device thereof | 上海嵘彩光电材料有限公司 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295028-A1 | CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | VDAC2, VDAC3, CYCS | CA12 1052/4885CA1 1910/4885CA2 1859/4885 |
| US-20260150576-A1 | HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | ESRRA, NR3C1, NR2C2 | CA12 1482/4885CA1 855/4885CA2 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.